Trial Profile
A first in human clinical trial of coronavirus neutralisng antibodies
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs Coronavirus neutralising antibodies 3rd Peoples Hospital of Shenzhen/Brii Biosciences/Tsinghua University (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; First in man
- 03 Apr 2020 New trial record
- 31 Mar 2020 According to a Tsinghua University media release, this study is planned for third quarter this year.